BRECCIA, MASSIMO
BRECCIA, MASSIMO
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
"Real-life" Frontline Dasatinib Treatment in Unselected Elderly Patients with Chronic Myeloid Leukemia
2014 Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Capodanno, I; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Breccia, M; Vigneri, Pg; Trawinska, Mm; Guarini, A; Alimena, G
"REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA
2015 Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Luciano, L; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Avanzini, P; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Tiribelli, M; Rizzo, M; Endri, M; Antolino, A; Breccia, M; Vigneri, P; Trawinska, Mm; Guarini, A; Alimena, G
"Real-life" results of front-line treatment with Imatinib in older patients (≥ 65 years) with newly diagnosed chronic myelogenous leukemia.
2010 Latagliata, R; Breccia, M; Carmosino, I; Cannella, L; De Cuia, R; Diverio, D; Frustaci, A; Loglisci, G; Mancini, M; Santopietro, M; Stefanizzi, Caterina; Volpicelli, P; Vozella, F; Alimena, Giuliana
(IN)EFFICIENCY OF 1ST LINE EPO APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL 5Q
2011 (IN)EFFICIENCY OF 1ST LINE EPO APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL, 5QFerretti A; Latagliata, R; Breccia, M; Girmenia, C; Mancini, M; Volpicelli, P; Vozella, F; Carmosino, I; Cannella, L; Federico, V; Loglisci, G; Alimena, G
2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA VALIDATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH 3 AVAILABLE TKIS OUTSIDE CLINICAL TRIALS
2016 Breccia, M; Pregno, P; Annunziata, M; Orlandi, E; Gozzini, A; Iurlo, A; Bocchia, M; Franceschini, L; Montefusco, E; Crugnola, M; La Nasa, G; Scortechini, Ar; Sgherza, N; Sica, S; Alimena, G; Saglio, G; Specchia, G
5 '-Azacitidine in myelodysplastic syndromes with inversion of chromosome 3
2011 M., Breccia; L., Cannella; M., Santopietro; G., Loglisci; V., Federico; A., Salaroli; M., Nanni; M., Mancini; Alimena, Giuliana
5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatment.
2011 Breccia, M; Salaroli, A; Loglisci, G; Martelli, Maurizio; D'Elia, Gm; Nanni, M; Mauro, Francesca Romana; Alimena, Giuliana
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials.
2012 Breccia, M; Loglisci, G; Salaroli, A; Serrao, A; Petrucci, L; Mancini, M; Alimena, Giuliana
5-AZACITIDINE FEASIBILITY AND SAFETY IN ELDERLY MYELODYSPLASTIC PATIENTS
2011 Breccia, M; Cannella, L; Mancini, M; Loglisci, G; Latagliata, R; Serrao, A; Santopietro, M; Salaroli, A; Alimena, G
5. Balanced and Unbalanced Chromosomal Translocatios in Myelodysplastic Syndromes: Clinical and Prognostic Signficance.
2020 Mohamed, S.; Latagliata, R.; Limongi, M. Z.; Nigro, S.; Sangiorgi, E.; Nanni, M.; Piccioni, A.; Campagna, A.; Aloe Spiriti, M. A.; Carmosino, I.; Molica, M.; Mariggiò, E.; Rosati, S.; Colafigli, G.; Fazio, F.; De Luca, M. L.; De Benedittis, D.; Scalzulli, E.; Breccia, M.; Mancini, M.
A 35 year single center transplant experience in chronic myeloid leukemia
2019 Bruzzese, Antonella; Barberi, Walter; Sperduti, Isabella; Latagliata, Roberto; Breccia, Massimo; Quattrocchi, Luisa; LA ROCCA, Ursula; Ansuinelli, Michela; Pepe, Sara; Foa, Roberto; Iori, ANNA PAOLA
A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
2022 Garcia-Gutierrez, Valentin; Breccia, Massimo; Jabbour, Elias; Mauro, Michael; Cortes, Jorge E.
A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
2015 Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G
A journey through infectious risk associated with ruxolitinib
2019 Sant'Antonio, Emanuela; Bonifacio, Massimiliano; Breccia, Massimo; Rumi, Elisa
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms
2020 Serrao, Alessandra; Breccia, Massimo; Napolitano, Mariasanta; Fiori, Luciano; Santoro, Marco; Scalzulli, Emilia; Santopietro, Michelina; Santoro, Cristina; Raso, Simona; Chistolini, Antonio
A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia
2011 Gianfelici, V; Diverio, D; Breccia, M; Buffolino, S; Derme, V; DI LASCIO, A; Marinelli, M; Santangelo, S; Foa, Roberto; Meloni, Giovanna
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with <= 30% blasts
2017 Garcia-Manero, G; Sekeres, Ma; Egyed, M; Breccia, M; Graux, C; Cavenagh, Jd; Salman, H; Illes, A; Fenaux, P; Deangelo, Dj; Stauder, R; Yee, K; Zhu, N; Lee, Jh; Valcarcel, D; Macwhannell, A; Borbenyi, Z; Gazi, L; Acharyya, S; Ide, S; Marker, M; Ottmann, Og
A Phase II, Single-Arm Study of De-Escalation and Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line Therapy Followed By a Second Attempt after Nilotinib and Asciminib Combination: Dante Study
2022 Rosti, Gianantonio; Saglio, Giuseppe; Stagno, Fabio; Valsecchi, Diletta; Nardozza, Aurelio Pio; Coco, Paola; Breccia, Massimo; Iurlo, Alessandra
A POPULATION-BASED STUDY OF MYELODYSPLASTIC SYNDROMES PATIENTS IN THE LAZIO REGION (ITALY), MISCODING IN MEDICAL CLAIMS AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY
2015 Mayer, F; Fenu, S; Agabiti, N; Buccisano, F; Latagliata, R; Ricci, R; Spiriti, Maa; Breccia, M; Cimino, G; Fianchi, L; Gumenyuk, S; Mancini, S; Maurillo, L; Nobile, C; Niscola, P; Piccioni, Al; Tafuri, A; Trape, G; Voso, Mt; Davoli, M; Zini, G
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up. The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry
2017 Mayer, Flavia; Faglioni, Laura; Agabiti, Nera; Fenu, Susanna; Buccisano, Francesco; Latagliata, Roberto; Ricci, Roberto; Aloe Spiriti, Maria Antonietta; Tatarelli, Caterina; Breccia, Massimo; Cimino, Giuseppe; Fianchi, Luana; Criscuolo, Marianna; Gumenyuk, Svitlana; Mancini, Stefano; Maurillo, Luca; Nobile, Carolina; Niscola, Pasquale; Piccioni, Anna Lina; Tafuri, Agostino; Trapã, Giulio; Andriani, Alessandro; De Fabritiis, Paolo; Voso, Maria Teresa; Davoli, Marina; Zini, Gina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Real-life" Frontline Dasatinib Treatment in Unselected Elderly Patients with Chronic Myeloid Leukemia | 2014 | Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Capodanno, I; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Breccia, M; Vigneri, Pg; Trawinska, Mm; Guarini, A; Alimena, G | |
| "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA | 2015 | Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Luciano, L; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Avanzini, P; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Tiribelli, M; Rizzo, M; Endri, M; Antolino, A; Breccia, M; Vigneri, P; Trawinska, Mm; Guarini, A; Alimena, G | |
| "Real-life" results of front-line treatment with Imatinib in older patients (≥ 65 years) with newly diagnosed chronic myelogenous leukemia. | 2010 | Latagliata, R; Breccia, M; Carmosino, I; Cannella, L; De Cuia, R; Diverio, D; Frustaci, A; Loglisci, G; Mancini, M; Santopietro, M; Stefanizzi, Caterina; Volpicelli, P; Vozella, F; Alimena, Giuliana | |
| (IN)EFFICIENCY OF 1ST LINE EPO APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL 5Q | 2011 | (IN)EFFICIENCY OF 1ST LINE EPO APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL, 5QFerretti A; Latagliata, R; Breccia, M; Girmenia, C; Mancini, M; Volpicelli, P; Vozella, F; Carmosino, I; Cannella, L; Federico, V; Loglisci, G; Alimena, G | |
| 2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA VALIDATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH 3 AVAILABLE TKIS OUTSIDE CLINICAL TRIALS | 2016 | Breccia, M; Pregno, P; Annunziata, M; Orlandi, E; Gozzini, A; Iurlo, A; Bocchia, M; Franceschini, L; Montefusco, E; Crugnola, M; La Nasa, G; Scortechini, Ar; Sgherza, N; Sica, S; Alimena, G; Saglio, G; Specchia, G | |
| 5 '-Azacitidine in myelodysplastic syndromes with inversion of chromosome 3 | 2011 | M., Breccia; L., Cannella; M., Santopietro; G., Loglisci; V., Federico; A., Salaroli; M., Nanni; M., Mancini; Alimena, Giuliana | |
| 5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatment. | 2011 | Breccia, M; Salaroli, A; Loglisci, G; Martelli, Maurizio; D'Elia, Gm; Nanni, M; Mauro, Francesca Romana; Alimena, Giuliana | |
| 5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials. | 2012 | Breccia, M; Loglisci, G; Salaroli, A; Serrao, A; Petrucci, L; Mancini, M; Alimena, Giuliana | |
| 5-AZACITIDINE FEASIBILITY AND SAFETY IN ELDERLY MYELODYSPLASTIC PATIENTS | 2011 | Breccia, M; Cannella, L; Mancini, M; Loglisci, G; Latagliata, R; Serrao, A; Santopietro, M; Salaroli, A; Alimena, G | |
| 5. Balanced and Unbalanced Chromosomal Translocatios in Myelodysplastic Syndromes: Clinical and Prognostic Signficance. | 2020 | Mohamed, S.; Latagliata, R.; Limongi, M. Z.; Nigro, S.; Sangiorgi, E.; Nanni, M.; Piccioni, A.; Campagna, A.; Aloe Spiriti, M. A.; Carmosino, I.; Molica, M.; Mariggiò, E.; Rosati, S.; Colafigli, G.; Fazio, F.; De Luca, M. L.; De Benedittis, D.; Scalzulli, E.; Breccia, M.; Mancini, M. | |
| A 35 year single center transplant experience in chronic myeloid leukemia | 2019 | Bruzzese, Antonella; Barberi, Walter; Sperduti, Isabella; Latagliata, Roberto; Breccia, Massimo; Quattrocchi, Luisa; LA ROCCA, Ursula; Ansuinelli, Michela; Pepe, Sara; Foa, Roberto; Iori, ANNA PAOLA | |
| A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase | 2022 | Garcia-Gutierrez, Valentin; Breccia, Massimo; Jabbour, Elias; Mauro, Michael; Cortes, Jorge E. | |
| A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS | 2015 | Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G | |
| A journey through infectious risk associated with ruxolitinib | 2019 | Sant'Antonio, Emanuela; Bonifacio, Massimiliano; Breccia, Massimo; Rumi, Elisa | |
| A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms | 2020 | Serrao, Alessandra; Breccia, Massimo; Napolitano, Mariasanta; Fiori, Luciano; Santoro, Marco; Scalzulli, Emilia; Santopietro, Michelina; Santoro, Cristina; Raso, Simona; Chistolini, Antonio | |
| A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia | 2011 | Gianfelici, V; Diverio, D; Breccia, M; Buffolino, S; Derme, V; DI LASCIO, A; Marinelli, M; Santangelo, S; Foa, Roberto; Meloni, Giovanna | |
| A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with <= 30% blasts | 2017 | Garcia-Manero, G; Sekeres, Ma; Egyed, M; Breccia, M; Graux, C; Cavenagh, Jd; Salman, H; Illes, A; Fenaux, P; Deangelo, Dj; Stauder, R; Yee, K; Zhu, N; Lee, Jh; Valcarcel, D; Macwhannell, A; Borbenyi, Z; Gazi, L; Acharyya, S; Ide, S; Marker, M; Ottmann, Og | |
| A Phase II, Single-Arm Study of De-Escalation and Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line Therapy Followed By a Second Attempt after Nilotinib and Asciminib Combination: Dante Study | 2022 | Rosti, Gianantonio; Saglio, Giuseppe; Stagno, Fabio; Valsecchi, Diletta; Nardozza, Aurelio Pio; Coco, Paola; Breccia, Massimo; Iurlo, Alessandra | |
| A POPULATION-BASED STUDY OF MYELODYSPLASTIC SYNDROMES PATIENTS IN THE LAZIO REGION (ITALY), MISCODING IN MEDICAL CLAIMS AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY | 2015 | Mayer, F; Fenu, S; Agabiti, N; Buccisano, F; Latagliata, R; Ricci, R; Spiriti, Maa; Breccia, M; Cimino, G; Fianchi, L; Gumenyuk, S; Mancini, S; Maurillo, L; Nobile, C; Niscola, P; Piccioni, Al; Tafuri, A; Trape, G; Voso, Mt; Davoli, M; Zini, G | |
| A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up. The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry | 2017 | Mayer, Flavia; Faglioni, Laura; Agabiti, Nera; Fenu, Susanna; Buccisano, Francesco; Latagliata, Roberto; Ricci, Roberto; Aloe Spiriti, Maria Antonietta; Tatarelli, Caterina; Breccia, Massimo; Cimino, Giuseppe; Fianchi, Luana; Criscuolo, Marianna; Gumenyuk, Svitlana; Mancini, Stefano; Maurillo, Luca; Nobile, Carolina; Niscola, Pasquale; Piccioni, Anna Lina; Tafuri, Agostino; Trapã, Giulio; Andriani, Alessandro; De Fabritiis, Paolo; Voso, Maria Teresa; Davoli, Marina; Zini, Gina |